Search

Your search keyword '"de Reuver PR"' showing total 131 results

Search Constraints

Start Over You searched for: Author "de Reuver PR" Remove constraint Author: "de Reuver PR"
131 results on '"de Reuver PR"'

Search Results

1. Pelvic Floor Rehabilitation After Rectal Cancer Surgery: A Multicenter Randomized Clinical Trial (FORCE Trial)

2. Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

3. Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study

5. Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort study

6. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

7. Mass-forming intrahepatic cholangiocarcinoma: treatment outcomes after curative-intent resection in an Australian tertiary referral hospital.

8. De-escalating surgical treatment in low stage gallbladder cancer.

9. An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry.

11. Restrictive Strategy vs Usual Care for Cholecystectomy in Patients With Abdominal Pain and Gallstones: 5-Year Follow-Up of the SECURE Randomized Clinical Trial.

12. 'IHPBA-APHPBA clinical practice guidelines': international Delphi consensus recommendations for gallbladder cancer.

13. [Gallstones].

14. Differences in patient- and tumor characteristics, treatment and survival between patients with screen-detected versus clinically detected colorectal peritoneal metastases.

16. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients.

17. Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

18. Referral rate of patients with incidental gallbladder cancer and survival: outcomes of a multicentre retrospective study.

20. Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation.

21. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials.

22. A mixed-methods study to define Textbook Outcome for the treatment of patients with uncomplicated symptomatic gallstone disease with hospital variation analyses in Dutch trial data.

24. Patients with Clinically Suspected Gallstone Disease: A More Selective Ultrasound May Improve Treatment Related Outcomes.

26. Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.

27. Treatment patterns and survival in older adults with unresected nonmetastatic biliary tract cancers.

28. Development and External Validation of a Model to Predict Overall Survival in Patients With Resected Gallbladder Cancer.

29. Oncological Safety and Potential Cost Savings of Routine vs Selective Histopathological Examination After Appendectomy: Results of the Multicenter, Prospective, Cross-Sectional FANCY Study.

30. The diagnostic value of staging laparoscopy in gallbladder cancer: a nationwide cohort study.

31. Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

32. Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.

34. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.

35. Tailoring diagnosis and treatment in symptomatic gallstone disease.

36. In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival.

38. Cost-effectiveness of Restrictive Strategy Versus Usual Care for Cholecystectomy in Patients With Gallstones and Abdominal Pain (SECURE-trial).

39. Metastasis in the gallbladder: does literature reflect reality?

40. Functional Dyspepsia and Irritable Bowel Syndrome are Highly Prevalent in Patients With Gallstones and Are Negatively Associated With Outcomes After Cholecystectomy: A Prospective, Multicenter, Observational Study (PERFECT - Trial).

41. Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin.

42. Safety and economic analysis of selective histopathology following cholecystectomy: multicentre, prospective, cross-sectional FANCY study.

43. Antibiotic prophylaxis for acute cholecystectomy: PEANUTS II multicentre randomized non-inferiority clinical trial.

44. Budget Impact of Restrictive Strategy Versus Usual Care for Cholecystectomy (SECURE-Trial).

45. Healthcare utilisation of patients with cholecystolithiasis in primary care: a multipractice comparative analysis.

46. Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications.

47. A Clinical Decision Tool for Selection of Patients With Symptomatic Cholelithiasis for Cholecystectomy Based on Reduction of Pain and a Pain-Free State Following Surgery.

48. Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.

49. Quality Assessment of Gallbladder Cancer Pathology Reports: A Dutch Nationwide Study.

50. 2020 WSES guidelines for the detection and management of bile duct injury during cholecystectomy.

Catalog

Books, media, physical & digital resources